Ivan Hyep, Chief Financial Officer at Bicara Therapeutics Inc. (BCAX), sold 12,830 shares at $18.23 ($234K) on 2025-10-09, disclosed to the SEC on 2025-10-10.
Scheduled sale ($234k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.23 | 6,415 | $117K | 50.0% |
| 2 | $18.23 | 6,415 | $117K | 50.0% |
| Total | $18.23 avg | 12,830 | $234K | 100% |
| Filing → |
| BCAX | SELL | 2026-05-26 | $188K | — | Filing → |
| BCAX | SELL | 2026-04-22 | $212K | — | Filing → |
| BCAX | SELL | 2026-03-24 | $341K | — | Filing → |